* Surmodics Inc SRDX.OQ reported a quarterly adjusted loss
of 10 cents per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 25 cents per share.
* Revenue rose 6.3% to $23.97 million from a year ago; analysts
expected $23.06 million.
* Surmodics Inc's reported EPS for the quarter was a loss of 2
cents.
* The mean earnings estimate of analysts was unchanged in the
last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Surmodics Inc shares had risen by 1.3% this quarter and
gained 29.4% so far this year.
* The company reported a quarterly loss of $289 thousand.
* Wall Street's median 12-month price target for Surmodics Inc
is $76.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated November 10 at 02:32 p.m.
All figures in US dollars unless otherwise stated